TRDA

Entrada Therapeutics Inc

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Entrada Therapeutics Inc (TRDA) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C+); its weakest is Revisions (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
C+
Factor Score 2.7 / 5.0
Growth
C-
Factor Score 2.0 / 5.0
Profitability
C+
Factor Score 2.7 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C-
Factor Score 2.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA 1.6
Rev Growth YoY -95.7%
Gross Margin N/M
Price Return 3M -49.7%
Price Return 12M 2.3%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 45.9
ROE -48.3%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-08-03 C+ (2.7) C- (2.0) C+ (2.7) C (2.4) C- (2.0) C (2.4)
2026-08-02 C+ (2.7) C- (2.0) C+ (2.7) C (2.4) C- (1.9) C (2.4)
2026-07-29 C+ (2.5) F (0.0) D+ (1.8) D- (0.9) D+ (1.5) D (1.4)
2025-06-30 C+ (2.6) F (0.0) D+ (1.8) D- (0.8) D+ (1.5) D (1.3)
2025-03-31 C+ (2.7) F (0.1) D+ (1.8) D- (1.0) D+ (1.5) D (1.4)
Page 1 of 3